Subclinical thyroid dysfunction and the risk for fractures: A systematic review and meta-analysis

Annals of Internal Medicine

Volumn 161, Issue 3, 2014, Pages 189-199

  Wirth, Christina D ^a,b   Blum, Manuel R ^a,b   Da Costa, Bruno R ^a,c   Baumgartner, Christine ^a,b   Collet, Tinh Hai ^a,d   Medici, Marco ^a,e   Peeters, Robin P ^a,e   Aujesky, Drahomir ^a,b   Bauer, Douglas C ^a,f   Rodondi, Nicolas ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN;

DISEASE ASSOCIATION; FRACTURE; HIP FRACTURE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PUBLISHING; QUALITY CONTROL; REVIEW; SUBCLINICAL HYPERTHYROIDISM; SUBCLINICAL HYPOTHYROIDISM; SYSTEMATIC REVIEW; THYROID DISEASE; THYROID FUNCTION;

FRACTURES, BONE; HIP FRACTURES; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; THYROID HORMONES;

EID: 84905657816     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M14-0125     Document Type: Review

References (65)

1. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526-34. [PMID: 10695693] (Pubitemid 30112276)
2. Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf). 1991;34:77-83. [PMID: 2004476]
3. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977;7:481-93. [PMID: 598014] (Pubitemid 8235965)
4. Helfand M; U.S. Preventive Services Task Force. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140:128-41. [PMID: 14734337]
5. Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, et al Thyroid Studies Collaboration. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304:1365-74. [PMID: 20858880]
6. Gencer B, Collet TH, Virgini V, Bauer DC, Gussekloo J, Cappola AR, et al Thyroid Studies Collaboration. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation. 2012;126:1040-9. [PMID: 22821943]
7. Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P, et al Thyroid Studies Collaboration. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med. 2012;172:799-809. [PMID: 22529182]
8. Waung JA, Bassett JH, Williams GR. Thyroid hormone metabolism in skeletal development and adult bone maintenance. Trends Endocrinol Metab. 2012;23:155-62. [PMID: 22169753]
9. Vestergaard P, Mosekilde L. Hyperthyroidism, bone mineral, and fracture risk - a meta-analysis. Thyroid. 2003;13:585-93. [PMID: 12930603] (Pubitemid 36842665)
10. Ahmed LA, Schirmer H, Berntsen GK, Fønnebø V, Joakimsen RM. Features of the metabolic syndrome and the risk of non-vertebral fractures: the Tromsø study. Osteoporos Int. 2006;17:426-32. [PMID: 16437192]
11. Vestergaard P, Rejnmark L, Mosekilde L. Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk. Calcif Tissue Int. 2005;77:139-44. [PMID: 16151671] (Pubitemid 41569743)
12. Lee JS, Buzková P, Fink HA, Vu J, Carbone L, Chen Z, et al. Subclinical thyroid dysfunction and incident hip fracture in older adults. Arch Intern Med. 2010;170:1876-83. [PMID: 21098345]
13. Waring AC, Harrison S, Fink HA, Samuels MH, Cawthon PM, Zmuda JM, et al Osteoporotic Fractures in Men (MrOS) Study. A prospective study of thyroid function, bone loss, and fractures in older men: The MrOS study. J Bone Miner Res. 2013;28:472-9. [PMID: 23018684]
14. Flynn RW, Bonellie SR, Jung RT, MacDonald TM, Morris AD, Leese GP. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab. 2010;95:186-93. [PMID: 19906785]
15. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489-99. [PMID: 11836274] (Pubitemid 34158210)
16. Hui SL, Slemenda CW, Johnston CC Jr. Baseline measurement of bone mass predicts fracture in white women. Ann Intern Med. 1989;111:355-61. [PMID: 2764403] (Pubitemid 19231288)
17. Drake MT, Murad MH, Mauck KF, Lane MA, Undavalli C, Elraiyah T, et al. Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97:1861-70. [PMID: 22466344]
18. Barrett JA, Baron JA, Karagas MR, Beach ML. Fracture risk in the U.S. Medicare population. J Clin Epidemiol. 1999;52:243-9. [PMID: 10210242] (Pubitemid 29148436)
19. Knudsen N, Laurberg P, Rasmussen LB, Bülow I, Perrild H, Ovesen L, et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab. 2005;90:4019-24. [PMID: 15870128]
20. De Laet C, Kanis JA, Odén A, Johanson H, Johnell O, Delmas P, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int. 2005;16:1330-8. [PMID: 15928804] (Pubitemid 41532085)
21. Asvold BO, Bjøro T, Nilsen TI, Vatten LJ. Tobacco smoking and thyroid function: a population-based study. Arch Intern Med. 2007;167:1428-32. [PMID: 17620538] (Pubitemid 47052443)
22. Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman JA, et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int. 2005;16:155-62. [PMID: 15175845] (Pubitemid 40193202)
23. Brabant G, Brabant A, Ranft U, Ocran K, Köhrle J, Hesch RD, et al. Circadian and pulsatile thyrotropin secretion in euthyroid man under the influence of thyroid hormone and glucocorticoid administration. J Clin Endocrinol Metab. 1987;65:83-8. [PMID: 3584402] (Pubitemid 17092092)
24. Kanis JA, Johansson H, Oden A, Johnell O, de Laet C, Melton III LJ, et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res. 2004;19:893-9. [PMID: 15125788] (Pubitemid 41103445)
25. Faber J, Galløe AM. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis. Eur J Endocrinol. 1994;130:350-6. [PMID: 8162163] (Pubitemid 24135720)
26. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab. 1996;81:4278-89. [PMID: 8954028] (Pubitemid 26412030)
27. Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J, et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med. 2008;148:832-45. [PMID: 18490668] (Pubitemid 351786932)
28. BMJ Evidence Centre. Study design search filters. London: BMJ; 2012. Accessed at http://clinicalevidence.bmj.com/x/set/static/ebm/learn/665076.html on 28 May 2013.
29. Chen Z, Kooperberg C, Pettinger MB, Bassford T, Cauley JA, LaCroix AZ, et al. Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women's Health Initiative observational study and clinical trials. Menopause. 2004;11:264-74. [PMID: 15167305] (Pubitemid 40362180)
30. Rodondi N, Aujesky D, Vittinghoff E, Cornuz J, Bauer DC. Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. Am J Med. 2006;119:541-51. [PMID: 16828622] (Pubitemid 44041257)
31. Egger M, Smith GD, Altman DG, eds. Systematic Reviews in Health Care: Meta-analysis in Context. 2nd ed. London: BMJ; 2001.
32. Hulley SB, Cummings SR, Browner WS, Grady DG, and Newman TB. Designing clinical research. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2007.
33. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228-38. [PMID: 14722150] (Pubitemid 38082818)
34. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA. 2006;295:1033-41. [PMID: 16507804]
35. Bauer DC, Ettinger B, Nevitt MC, Stone KL; Study of Osteoporotic Fractures Research Group. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med. 2001;134:561-8. [PMID: 12803168] (Pubitemid 32245317)
36. Svare A, Nilsen TI, Asvold BO, Forsmo S, Schei B, Bjøro T, et al. Does thyroid function influence fracture risk? Prospective data from the HUNT2 study, Norway. Eur J Endocrinol. 2013;169:845-52. [PMID: 24031093]
37. Knapp G, Hartung J. Improved tests for a random effects meta-regression with a single covariate. Stat Med. 2003;22:2693-710. [PMID: 12939780] (Pubitemid 37038351)
38. Cornell JE, Mulrow CD, Localio R, Stack CB, Meibohm AR, Guallar E, et al. Random-effects meta-analysis of inconsistent effects: a time for change. Ann Intern Med. 2014;160:267-70. [PMID: 24727843]
39. Petitti DB. Approaches to heterogeneity in meta-analysis. Stat Med. 2001;20:3625-33. [PMID: 11746342] (Pubitemid 33114432)
40. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60. [PMID: 12958120] (Pubitemid 37088507)
41. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-101. [PMID: 7786990]
42. Sterne JA, Egger M, Smith GD. Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ. 2001;323:101-5. [PMID: 11451790] (Pubitemid 32681979)
43. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264-9. [PMID: 19622511]
44. van der Deure WM, Uitterlinden AG, Hofman A, Rivadeneira F, Pols HA, Peeters RP, et al. Effects of serum TSH and FT4 levels and the TSHR-Review Asp727Glu polymorphism on bone: the Rotterdam Study. Clin Endocrinol (Oxf). 2008;68:175-81. [PMID: 17803697]
45. Hofman A, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, Ikram MA, et al. The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol. 2013;28:889-926. [PMID: 24258680]
46. Finigan J, Greenfield DM, Blumsohn A, Hannon RA, Peel NF, Jiang G, et al. Risk factors for vertebral and nonvertebral fracture over 10 years: a population-based study in women. J Bone Miner Res. 2008;23:75-85. [PMID: 17784843]
47. Faber J, Jensen IW, Petersen L, Nygaard B, Hegedüs L, Siersbaek-Nielsen K. Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women. Clin Endocrinol (Oxf). 1998;48:285-90. [PMID: 9578817] (Pubitemid 28137639)
48. Mudde AH, Houben AJ, Nieuwenhuijzen Kruseman AC. Bone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism. Clin Endocrinol (Oxf). 1994;41:421-4. [PMID: 7955452] (Pubitemid 24301273)
49. Taylor PN, Razvi S, Pearce SH, Dayan CM. Clinical review: A review of the clinical consequences of variation in thyroid function within the reference range. J Clin Endocrinol Metab. 2013;98:3562-71. [PMID: 23824418]
50. Toft AD. Clinical practice. Subclinical hyperthyroidism. N Engl J Med. 2001;345:512-6. [PMID: 11519506]
51. Biondi B, Palmieri EA, Klain M, Schlumberger M, Filetti S, Lombardi G. Subclinical hyperthyroidism: clinical features and treatment options. Eur J Endocrinol. 2005;152:1-9. [PMID: 15762182] (Pubitemid 40185448)
52. Morrison A, Fan T, Sen SS, Weisenfluh L. Epidemiology of falls and osteoporotic fractures: a systematic review. Clinicoecon Outcomes Res. 2013;5:9-18. [PMID: 23300349]
53. Brennan MD, Powell C, Kaufman KR, Sun PC, Bahn RS, Nair KS. The impact of overt and subclinical hyperthyroidism on skeletal muscle. Thyroid. 2006;16:375-80. [PMID: 16646684]
54. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29:76-131. [PMID: 17991805] (Pubitemid 351252748)
55. Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res. 2002;17:1237-44. [PMID: 12096837] (Pubitemid 34680500)
56. Meier C, Beat M, Guglielmetti M, Christ-Crain M, Staub JJ, Kraenzlin M. Restoration of euthyroidism accelerates bone turnover in patients with subclinical hypothyroidism: a randomized controlled trial. Osteoporos Int. 2004;15:209-16. [PMID: 14727010] (Pubitemid 38391536)
57. Vestergaard P, Mosekilde L. Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid. 2002;12:411-9. [PMID: 12097203] (Pubitemid 34602601)
58. Egger M, Smith GD. Meta-Analysis. Potentials and promise. BMJ. 1997;315:1371-4. [PMID: 9432250] (Pubitemid 27499747)
59. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-12. [PMID: 10789670] (Pubitemid 30214957)
60. Díez JJ, Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab. 2004;89:4890-7. [PMID: 15472181] (Pubitemid 39391424)
61. Das G, Ojewuyi TA, Baglioni P, Geen J, Premawardhana LD, Okosieme OE. Serum thyrotrophin at baseline predicts the natural course of subclinical hyperthyroidism. Clin Endocrinol (Oxf). 2012;77:146-51. [PMID: 22283624]
62. Berlin JA, Santanna J, Schmid CH, Szczech LA, Feldman HI; Anti-Lymphocyte Antibody Induction Therapy Study Group. Individual patient-versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med. 2002;21:371-87. [PMID: 11813224] (Pubitemid 34144648)
63. Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al American Thyroid Association. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract. 2011;17:456-520. [PMID: 21700562]
64. Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012;379:1142-54. [PMID: 22273398]
65. Rodondi N, Bauer DC. Subclinical hypothyroidism and cardiovascular risk: how to end the controversy [Editorial]. J Clin Endocrinol Metab. 2013;98:2267-9. [PMID: 23633199]